应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09966 康宁杰瑞制药-B
未开盘 07-03 16:08:13
2.350
-0.010
-0.42%
最高
2.400
最低
2.320
成交量
273.40万
今开
2.360
昨收
2.360
日振幅
3.39%
总市值
22.68亿
流通市值
22.68亿
总股本
9.65亿
成交额
644.16万
换手率
0.28%
流通股本
9.65亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康宁杰瑞制药-B盘中异动 大幅上涨5.06%报2.491港元
自选股智能写手 · 06-26
康宁杰瑞制药-B盘中异动 大幅上涨5.06%报2.491港元
康宁杰瑞制药-B(09966)股价上升5.063%,现价港币$2.49
阿斯达克财经 · 06-26
康宁杰瑞制药-B(09966)股价上升5.063%,现价港币$2.49
多领域展现巨大应用潜力 双抗药物进入“寻宝”竞速赛
第一财经 · 06-25
多领域展现巨大应用潜力 双抗药物进入“寻宝”竞速赛
康宁杰瑞制药-B(09966)股价下跌5.039%,现价港币$2.45
阿斯达克财经 · 06-24
康宁杰瑞制药-B(09966)股价下跌5.039%,现价港币$2.45
康宁杰瑞制药-B盘中异动 股价大涨5.06%
自选股智能写手 · 06-19
康宁杰瑞制药-B盘中异动 股价大涨5.06%
康宁杰瑞制药-B(09966)股价上升5.058%,现价港币$2.7
阿斯达克财经 · 06-19
康宁杰瑞制药-B(09966)股价上升5.058%,现价港币$2.7
康宁杰瑞制药-B06月14日主力资金流出2万元 连续3日减仓
自选股智能写手 · 06-14
康宁杰瑞制药-B06月14日主力资金流出2万元 连续3日减仓
康宁杰瑞制药-B盘中异动 早盘快速跳水5.22%报2.721港元
自选股智能写手 · 06-12
康宁杰瑞制药-B盘中异动 早盘快速跳水5.22%报2.721港元
康宁杰瑞制药-B盘中异动 早盘快速上涨5.17%报3.030港元
自选股智能写手 · 06-07
康宁杰瑞制药-B盘中异动 早盘快速上涨5.17%报3.030港元
康宁杰瑞与ArriVent就ADC产品研发和商业化达成合作
美通社 · 06-06
康宁杰瑞与ArriVent就ADC产品研发和商业化达成合作
亚洲水泥(中国)00743私有化提折价3.01% 康宁杰瑞制药-B09966与ArriVent合作ADC产品研究开发商业化
和讯网 · 06-05
亚洲水泥(中国)00743私有化提折价3.01% 康宁杰瑞制药-B09966与ArriVent合作ADC产品研究开发商业化
康宁杰瑞制药-B(09966)附属与ArriVent就ADC产品的研究、开发及商业化达成合作
智通财经 · 06-05
康宁杰瑞制药-B(09966)附属与ArriVent就ADC产品的研究、开发及商业化达成合作
康宁杰瑞制药-B早盘飙涨20%,港股医药ETF(159718)一度涨超1%
有连云 · 06-05
康宁杰瑞制药-B早盘飙涨20%,港股医药ETF(159718)一度涨超1%
非农数据“前哨战”告捷支撑创新药板块情绪,港股创新药ETF(159567)跟踪指数走势较强,康宁杰瑞制药-B、百济神州、亚盛医药-B领涨。
有连云 · 06-05
非农数据“前哨战”告捷支撑创新药板块情绪,港股创新药ETF(159567)跟踪指数走势较强,康宁杰瑞制药-B、百济神州、亚盛医药-B领涨。
ASCO会议发布众多新药成果,康宁杰瑞制药-B涨超17%,恒生医疗ETF(513060)成交额超3亿元
有连云 · 06-05
ASCO会议发布众多新药成果,康宁杰瑞制药-B涨超17%,恒生医疗ETF(513060)成交额超3亿元
东曜药业-B盘中异动 早盘急速拉升5.39%报2.151港元
自选股智能写手 · 06-05
东曜药业-B盘中异动 早盘急速拉升5.39%报2.151港元
港股异动 | 康宁杰瑞制药-B(09966)飙升19% 治疗晚期实体瘤药物临床研究显示耐受性良好
智通财经 · 06-05
港股异动 | 康宁杰瑞制药-B(09966)飙升19% 治疗晚期实体瘤药物临床研究显示耐受性良好
康宁杰瑞制药-B盘中异动 股价大涨5.30%报2.760港元
自选股智能写手 · 06-05
康宁杰瑞制药-B盘中异动 股价大涨5.30%报2.760港元
康宁杰瑞制药-B(09966)股价上升5.344%,现价港币$2.76
阿斯达克财经 · 06-05
康宁杰瑞制药-B(09966)股价上升5.344%,现价港币$2.76
暂无数据
公司概况
公司名称:
康宁杰瑞制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台,包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":2.35,"timestamp":1719994093022,"preClose":2.36,"halted":0,"volume":2734000,"delay":0,"floatShares":964923807,"shares":964923807,"eps":-0.23462681,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.01,"latestTime":"07-03 16:08:13","open":2.36,"high":2.4,"low":2.32,"amount":6441570,"amplitude":0.033898,"askPrice":2.36,"askSize":12000,"bidPrice":2.32,"bidSize":47000,"shortable":3,"etf":0,"ttmEps":-0.2352791858349019,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720056600000},"adr":0,"listingDate":1576080000000,"adjPreClose":2.36,"openAndCloseTimeList":[[1719970200000,1719979200000],[1719982800000,1719993600000]],"volumeRatio":0.825982,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966/tweets","defaultTab":"tweets","newsList":[{"id":"2446537503","title":"康宁杰瑞制药-B盘中异动 大幅上涨5.06%报2.491港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446537503","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446537503?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:50","pubTimestamp":1719388233,"startTime":"0","endTime":"0","summary":"2024年06月26日临近收盘15时50分,康宁杰瑞制药-B股票出现异动,股价急速上涨5.06%。截至发稿,该股报2.491港元/股,成交量297.9万股,换手率0.31%,振幅5.91%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,君实生物、迈博药业-B、基石药业-B涨幅较大,振幅较大的相关个股有歌礼制药-B、帝王国际投资、圣诺医药-B,振幅分别为16.67%、14.52%、12.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626155034af8f4625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626155034af8f4625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2446486353","title":"康宁杰瑞制药-B(09966)股价上升5.063%,现价港币$2.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2446486353","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446486353?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:50","pubTimestamp":1719388200,"startTime":"0","endTime":"0","summary":"[上升股]康宁杰瑞制药-B(09966) 股价在下午03:50比前收市价上升5.063%,现股价为港币$2.49。至目前为止,今日最高价为$2.49,而最低价为$2.35。总成交量为297.9万股,总成交金额为港币$722.875万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2406261301/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2446813440","title":"多领域展现巨大应用潜力 双抗药物进入“寻宝”竞速赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2446813440","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446813440?lang=zh_cn&edition=full","pubTime":"2024-06-25 18:04","pubTimestamp":1719309866,"startTime":"0","endTime":"0","summary":"在上月召开的ASCO2024会议上,多家中国创新药企披露了在研双抗药物的临床数据,其中,康方生物(09926.HK)披露其已上市的双抗药物依沃西在对比K药一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌的III期临床试验中,呈现出显著优于后者的疗效,成为全球首款在III期单药头对头临床试验中击败K药的创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202406253113233195.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202406253113233195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999001176.USD","SG9999014559.SGD","BK1515","SG9999014567.USD","MRK","09926","LU0861579265.USD","LU1720050803.USD","BK4585","IE00BFTCPJ56.SGD","SG9999002232.USD","BK4588","LU1989771016.USD","SG9999001176.SGD","L","LU1989772923.USD","IE0002141913.USD","LU2461242641.AUD","LU0348784397.USD","IE0009355771.USD","LU1093756325.SGD","09966","LU0058720904.USD","01177","SG9999002224.SGD","LU0417516571.SGD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4559","IE00BJT1NW94.SGD","LU2361045086.USD","BK4516","BK1589","LU1066051498.USD","IE00B1BXHZ80.USD","LU0211331839.USD","LU0053666078.USD","LU2361044865.SGD","BK1161","BK1191","BK4533","LU0122379950.USD","LU1989772840.SGD","IE00BBT3K403.USD","BK4550","LU1917777945.USD","LU2023250504.SGD","LU1066053197.SGD","BK4007"],"gpt_icon":0},{"id":"2445016830","title":"康宁杰瑞制药-B(09966)股价下跌5.039%,现价港币$2.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2445016830","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445016830?lang=zh_cn&edition=full","pubTime":"2024-06-24 11:49","pubTimestamp":1719200940,"startTime":"0","endTime":"0","summary":"[下跌股]康宁杰瑞制药-B(09966) 股价在上午11:49比前收市价下跌5.039%,现股价为港币$2.45。至目前为止,今日最高价为$2.59,而最低价为$2.45。总成交量为232.3万股,总成交金额为港币$581.202万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406241999/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2444582449","title":"康宁杰瑞制药-B盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444582449","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444582449?lang=zh_cn&edition=full","pubTime":"2024-06-19 15:05","pubTimestamp":1718780747,"startTime":"0","endTime":"0","summary":"2024年06月19日下午盘15时05分,康宁杰瑞制药-B股票出现波动,股价大幅上涨5.06%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,友芝友生物-B、北海康成-B、康宁杰瑞制药-B涨幅较大,振幅较大的相关个股有北海康成-B、绿竹生物-B、中国抗体-B,振幅分别为25.00%、11.63%、11.18%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619150547941ef783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619150547941ef783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2444449444","title":"康宁杰瑞制药-B(09966)股价上升5.058%,现价港币$2.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2444449444","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444449444?lang=zh_cn&edition=full","pubTime":"2024-06-19 15:05","pubTimestamp":1718780700,"startTime":"0","endTime":"0","summary":"[上升股]康宁杰瑞制药-B(09966) 股价在下午03:05比前收市价上升5.058%,现股价为港币$2.7。至目前为止,今日最高价为$2.7,而最低价为$2.58。总成交量为329.6万股,总成交金额为港币$868.522万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2406195769/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2443648972","title":"康宁杰瑞制药-B06月14日主力资金流出2万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2443648972","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443648972?lang=zh_cn&edition=full","pubTime":"2024-06-14 16:17","pubTimestamp":1718353027,"startTime":"0","endTime":"0","summary":"06月14日, 康宁杰瑞制药-B股价涨0.37%,报收2.68元,成交金额1044万元,换手率0.40%,振幅2.62%,量比0.28。康宁杰瑞制药-B今日主力资金净流出2万元,连续3日净流出,上一交易日主力净流出171万元,今日环比减少98.83%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为8.01%。该股近5个交易日下跌6.94%,主力资金累计净流出468万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出181万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141617449f3c2c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141617449f3c2c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2442249371","title":"康宁杰瑞制药-B盘中异动 早盘快速跳水5.22%报2.721港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442249371","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442249371?lang=zh_cn&edition=full","pubTime":"2024-06-12 10:09","pubTimestamp":1718158143,"startTime":"0","endTime":"0","summary":"2024年06月12日早盘10时09分,康宁杰瑞制药-B股票出现波动,股价急速跳水5.22%。截至发稿,该股报2.721港元/股,成交量324.7万股,换手率0.34%,振幅6.27%。资金方面,该股资金流入131.988万港元,流出454.061万港元。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.29%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061210090396813914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061210090396813914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2441835701","title":"康宁杰瑞制药-B盘中异动 早盘快速上涨5.17%报3.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441835701","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441835701?lang=zh_cn&edition=full","pubTime":"2024-06-07 10:18","pubTimestamp":1717726691,"startTime":"0","endTime":"0","summary":"2024年06月07日早盘10时18分,康宁杰瑞制药-B股票出现波动,股价急速上涨5.17%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,科济药业-B、康宁杰瑞制药-B、金斯瑞生物科技涨幅较大,振幅较大的相关个股有科伦博泰生物-B、科济药业-B、盛禾生物-B,振幅分别为8.98%、7.53%、7.17%。消息层面,截至10时18分,康宁杰瑞制药-B股票正面舆情新闻比例14.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607101812941ed272&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607101812941ed272&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2441730726","title":"康宁杰瑞与ArriVent就ADC产品研发和商业化达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2441730726","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441730726?lang=zh_cn&edition=full","pubTime":"2024-06-06 10:19","pubTimestamp":1717640340,"startTime":"0","endTime":"0","summary":"在大中华区以外的国家和地区,ArriVent将拥有相关ADC产品肿瘤领域的开发及商业化的独家权利,并将负责及承担ADC产品的相应开发费用支出。根据协议条款,康宁杰瑞有权收取一次性、不可退还的预付款,以及潜在的里程碑付款,包括产品注册、开发及销售里程碑款项,总计高达6.155亿美元。此外,康宁杰瑞还有权就各ADC产品向ArriVent收取分级销售特许权使用费。此次合作结合了康宁杰瑞ADC药物的研发能力和ArriVent在肿瘤领域丰富的开发经验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4433095_ZH33095_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["09966","ADC","BK4231","BK1574","BK4585","GLW","BK1161","LU0348723411.USD","BK4080","BK4588","BK4148","BK4512"],"gpt_icon":0},{"id":"2441178750","title":"亚洲水泥(中国)00743私有化提折价3.01% 康宁杰瑞制药-B09966与ArriVent合作ADC产品研究开发商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2441178750","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441178750?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:50","pubTimestamp":1717602645,"startTime":"0","endTime":"0","summary":"快讯正文【亚洲水泥(中国)获控股股东折价私有化,6月6日复牌】亚洲水泥(中国)近日宣布,其控股股东提出私有化计划,折价约3.01%。公司股票将于6月6日恢复交易。同时,康宁杰瑞制药-B宣布其附属公司与ArriVent达成合作协议,共同推进ADC产品的研究、开发及商业化。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406060659109f1e22ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406060659109f1e22ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00743","BK1574","BK1563","09966","BK1135","BK1161","BK1594"],"gpt_icon":0},{"id":"2441224736","title":"康宁杰瑞制药-B(09966)附属与ArriVent就ADC产品的研究、开发及商业化达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2441224736","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441224736?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:02","pubTimestamp":1717578141,"startTime":"0","endTime":"0","summary":"在大中华区以外的国家和地区,ArriVent将拥有相关ADC产品于肿瘤领域的开发及商业化的独家权利,并将负责及承担ADC产品的相应开发费用支出。根据合作协议,康宁杰瑞有权收取一次性、不可退还的预付款以及潜在里程碑付款,包括产品注册、开发及销售里程碑款项,总计高达6.16亿美元。此外,康宁杰瑞亦有权就各ADC产品向ArriVent收取分级销售特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","ADC","BK4080","09966","BK1161","BK4231"],"gpt_icon":0},{"id":"2441218965","title":"康宁杰瑞制药-B早盘飙涨20%,港股医药ETF(159718)一度涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441218965","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441218965?lang=zh_cn&edition=full","pubTime":"2024-06-05 11:21","pubTimestamp":1717557703,"startTime":"0","endTime":"0","summary":"截至2024年6月5日 11:06,港股医药ETF早盘红盘震荡,一度涨超1%,最新价报0.56元,盘中成交额已达1174.32万元,换手率6.45%。规模方面,港股医药ETF近1年规模增长1.15亿元,实现显著增长。今日,康宁杰瑞制药-B早盘飙升20.61%,领涨成分股。消息面上,康宁杰瑞制药日前宣布,其靶向HER2双表位的新型抗体偶联药物JSKN003治疗HER2表达实体瘤的中国I期临床研究数据在2024年ASCO年会上首次公布。港股医药ETF,场外联接。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051121459f1b20ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051121459f1b20ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","09966","07226","BK1161","HSCEI","BK1574"],"gpt_icon":0},{"id":"2441977992","title":"非农数据“前哨战”告捷支撑创新药板块情绪,港股创新药ETF(159567)跟踪指数走势较强,康宁杰瑞制药-B、百济神州、亚盛医药-B领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441977992","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441977992?lang=zh_cn&edition=full","pubTime":"2024-06-05 11:01","pubTimestamp":1717556502,"startTime":"0","endTime":"0","summary":"2024年6月5日,港股创新药板块走势占优。盘面上,康宁杰瑞制药-B领涨,百济神州、亚盛医药-B跟涨,港股创新药ETF市场热度较高,过去5个交易日日均成交额达到8234万元。消息面上,美国非农就业数据“前哨战”JOLTS职位空缺创两年来新低,指示美国市场劳动力降温,降息预期边际强化,利好创新药板块投融资。创新药板块多数公司2023年消极因素集中出清,24Q1迎来拐点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605110146958f8153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605110146958f8153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159567","BK0239","06160","06855","513120","BGNE","159938","159992","688235","09966"],"gpt_icon":0},{"id":"2441297374","title":"ASCO会议发布众多新药成果,康宁杰瑞制药-B涨超17%,恒生医疗ETF(513060)成交额超3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441297374","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441297374?lang=zh_cn&edition=full","pubTime":"2024-06-05 10:51","pubTimestamp":1717555907,"startTime":"0","endTime":"0","summary":"隔夜美股三大指数均小幅收涨,港股继续反弹行情,恒指涨0.25%,国指涨0.19%,恒生科技指数涨0.03%。恒生医疗ETF连续2日上涨,今日涨超1%,成交额超3亿元,盘中溢价交易,溢折率0.14%。恒生医疗ETF跟踪恒生医疗保健指数,成分股覆盖CXO、生物科技、医疗器械、中药、互联网医疗企业和创新药多个细分领域。消息面看,多家中国创新药企将于ASCO发布最新成果。中国创新药出海趋势明确,2024年亦有多项海外权益授权达成,并且形式更加多元化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051051519f1b0641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051051519f1b0641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2441928290","title":"东曜药业-B盘中异动 早盘急速拉升5.39%报2.151港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441928290","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441928290?lang=zh_cn&edition=full","pubTime":"2024-06-05 10:50","pubTimestamp":1717555843,"startTime":"0","endTime":"0","summary":"2024年06月05日早盘10时50分,东曜药业-B股票出现异动,股价快速上涨5.39%。截至发稿,该股报2.151港元/股,成交量10000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入2.15万港元,流出0港元。东曜药业-B股票所在的生物技术行业中,整体涨幅为1.45%。东曜药业-B公司简介:东曜药业股份有限公司是一家主要从事开发及商业化肿瘤药物及疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605105044af8c0eb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605105044af8c0eb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09966","01875","BK1161"],"gpt_icon":0},{"id":"2441292600","title":"港股异动 | 康宁杰瑞制药-B(09966)飙升19% 治疗晚期实体瘤药物临床研究显示耐受性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2441292600","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441292600?lang=zh_cn&edition=full","pubTime":"2024-06-05 10:36","pubTimestamp":1717554966,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康宁杰瑞制药-B(09966)飙升19%,截至发稿,涨19.08%,报3.02港元,成交额8700.57万港元。消息面上,康宁杰瑞制药日前宣布,其靶向HER2双表位的新型抗体偶联药物(ADC)JSKN003治疗HER2表达实体瘤的中国I期临床研究数据在2024年ASCO年会上首次公布。研究结论显示,JSKN003在既往经多线系统治疗的晚期/转移性实体瘤患者中,具有良好的耐受性和可控的安全性。目前JSKN003在澳大利亚和中国的多项临床研究正在顺利进行,治疗晚期HER2低表达乳腺癌的中国关键临床研究也在积极推进中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1161","HSCEI","BK1574","YANG","07226","09966"],"gpt_icon":0},{"id":"2441729174","title":"康宁杰瑞制药-B盘中异动 股价大涨5.30%报2.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441729174","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441729174?lang=zh_cn&edition=full","pubTime":"2024-06-05 10:05","pubTimestamp":1717553136,"startTime":"0","endTime":"0","summary":"2024年06月05日早盘10时05分,康宁杰瑞制药-B股票出现波动,股价快速拉升5.30%。截至发稿,该股报2.760港元/股,成交量380.5万股,换手率0.39%,振幅6.11%。康宁杰瑞制药-B股票所在的生物技术行业中,整体涨幅为1.17%。其相关个股中,百济神州、康诺亚-B、康宁杰瑞制药-B涨幅较大,振幅较大的相关个股有康诺亚-B、科伦博泰生物-B、博安生物,振幅分别为6.19%、6.08%、5.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605100536af8c0ca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605100536af8c0ca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2441946642","title":"康宁杰瑞制药-B(09966)股价上升5.344%,现价港币$2.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2441946642","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441946642?lang=zh_cn&edition=full","pubTime":"2024-06-05 10:05","pubTimestamp":1717553100,"startTime":"0","endTime":"0","summary":"[上升股]康宁杰瑞制药-B(09966) 股价在上午10:05比前收市价上升5.344%,现股价为港币$2.76。至目前为止,今日最高价为$2.76,而最低价为$2.6。总成交量为380.2万股,总成交金额为港币$1.022千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2406051868/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09966","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0524},{"period":"3month","weight":-0.4946},{"period":"6month","weight":-0.6197},{"period":"1year","weight":-0.7077},{"period":"ytd","weight":-0.6461}],"compareEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.0231},{"period":"3month","weight":0.0749},{"period":"6month","weight":0.0873},{"period":"1year","weight":-0.074},{"period":"ytd","weight":0.0546}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台,包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.131218},{"month":2,"riseRate":0.6,"avgChangeRate":0.11167},{"month":3,"riseRate":0,"avgChangeRate":-0.116679},{"month":4,"riseRate":1,"avgChangeRate":0.117691},{"month":5,"riseRate":0.4,"avgChangeRate":-0.096701},{"month":6,"riseRate":0.4,"avgChangeRate":0.026634},{"month":7,"riseRate":0.2,"avgChangeRate":-0.042366},{"month":8,"riseRate":0.25,"avgChangeRate":0.023258},{"month":9,"riseRate":0,"avgChangeRate":-0.110125},{"month":10,"riseRate":0.5,"avgChangeRate":0.045929},{"month":11,"riseRate":0.5,"avgChangeRate":0.076762},{"month":12,"riseRate":0.75,"avgChangeRate":0.015223}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}